Today18 events
To consider and approve standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026, and to recommend final dividend.
To consider and approve the Audited Financial Results for the fourth quarter and year ended 31st March, 2026.
To consider and approve audited financial results for the quarter and year ended March 31, 2026.
To consider audited standalone and consolidated financial results for the year ended on March 31, 2026.
To consider and approve the Audited Standalone and Consolidated Financial Results and Statements of the Company for the fourth quarter and financial year ended 31st March 2026.
To consider and approve audited financial results for the financial year ended March 31, 2026, and to recommend dividend.
The Board of Directors will meet to consider, approve and take on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. They will also consider a proposal to recommend a final dividend for the financial year ended March 31, 2026.
To consider and approve the audited financial results for the quarter and financial year ended March 31, 2026, and to recommend dividend on equity shares, if any.
To consider and approve the annual audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. Also, to consider and recommend final dividend and discuss matters relating to the ensuing Annual General Meeting.
To consider and approve audited financial results for the quarter and year ended March 31, 2026. The Board may also consider recommendation of final dividend.
To consider increasing the authorized share capital and approve a material related party transaction for revision in project cost.
To consider and approve the audited financial results for the quarter and financial year ended 31 March 2026.
To consider and approve financial results for the quarter and year ended March 31, 2026, declare distributions to unitholders, and raise debt.
To consider and approve Audited Financial Results for the 4th quarter and financial year ended March 31, 2026, and to consider and recommend Final Dividend, if any.
To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026, and to consider recommending Dividend, if any.
To consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider the recommendation of dividend.
To consider and approve the unaudited (standalone & consolidated) financial results for the quarter and nine months ended 31st March, 2026.
To consider and approve standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, and to consider recommendation of final dividend.
To take on record and approve the certificate issued by M/s. PAMS & Associates, Statutory Auditors, pursuant to Regulation 45(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
To consider increasing the authorized share capital and altering the capital and object clauses of the Memorandum of Association.
To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ending on March 31, 2026.
An Extra Ordinary General Meeting will be held to consider and pass a resolution to increase the authorised share capital of the company.